Financial results - LOTUS PHARMEDICALS SRL

Financial Summary - Lotus Pharmedicals Srl
Unique identification code: 2205118
Registration number: J1991001673247
Nace: 4645
Sales - Ron
318.790
Net Profit - Ron
42.241
Employees
3
Open Account
Company Lotus Pharmedicals Srl with Fiscal Code 2205118 recorded a turnover of 2024 of 318.790, with a net profit of 42.241 and having an average number of employees of 3. The company operates in the field of Comerţ cu ridicata al produselor cosmetice şi de parfumerie having the NACE code 4645.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Lotus Pharmedicals Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 418.467 486.927 431.265 362.740 364.245 391.786 339.827 348.184 341.539 318.790
Total Income - EUR 424.174 491.232 434.558 366.349 365.592 395.656 341.610 351.635 342.984 319.115
Total Expenses - EUR 387.614 406.270 365.410 314.609 318.155 353.225 279.889 293.515 309.463 267.301
Gross Profit/Loss - EUR 36.560 84.962 69.149 51.740 47.437 42.431 61.721 58.120 33.521 51.814
Net Profit/Loss - EUR 28.897 71.368 64.434 48.108 43.792 38.513 58.322 54.629 30.098 42.241
Employees 7 7 8 7 6 6 4 0 4 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -6.1%, from 341.539 euro in the year 2023, to 318.790 euro in 2024. The Net Profit increased by 12.311 euro, from 30.098 euro in 2023, to 42.241 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Lotus Pharmedicals Srl

Rating financiar

Financial Rating -
LOTUS PHARMEDICALS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Lotus Pharmedicals Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Lotus Pharmedicals Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Lotus Pharmedicals Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Lotus Pharmedicals Srl - CUI 2205118

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 66.957 62.468 60.451 56.181 52.151 48.277 44.619 42.156 39.457 37.676
Current Assets 393.765 428.980 416.867 393.254 385.376 379.157 398.254 409.693 376.713 407.662
Inventories 126.154 103.340 99.745 114.973 88.225 118.705 153.050 111.060 81.778 59.840
Receivables 230.070 228.162 222.477 204.876 173.925 202.613 187.926 218.084 155.926 175.767
Cash 37.541 97.478 94.645 73.405 123.225 57.839 57.278 80.549 139.009 172.055
Shareholders Funds 438.355 476.265 461.397 436.986 424.273 411.184 421.824 419.810 393.221 402.957
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 22.367 15.183 15.921 12.449 13.253 16.249 21.050 32.039 22.949 42.381
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4645 - 4645"
CAEN Financial Year 4645
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 407.662 euro in 2024 which includes Inventories of 59.840 euro, Receivables of 175.767 euro and cash availability of 172.055 euro.
The company's Equity was valued at 402.957 euro, while total Liabilities amounted to 42.381 euro. Equity increased by 11.934 euro, from 393.221 euro in 2023, to 402.957 in 2024.

Risk Reports Prices

Reviews - Lotus Pharmedicals Srl

Comments - Lotus Pharmedicals Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.